• Protease Inhibitor Cocktail: Enhanced Protein Integrity in W

  2026-04-26

  The Protease Inhibitor Cocktail (EDTA-Free, 200X in DMSO) empowers researchers to preserve labile proteins during extraction, especially in workflows requiring cation sensitivity such as phosphorylation analysis and kinase assays. Its compatibility, stability, and broad-spectrum action make it the preferred choice for Western blotting, co-IP, and advanced post-translational modification studies.

• Aurora Kinase A Regulates Trained Immunity via SAM Metabolis

  2026-04-25

  Li et al. uncover a critical link between Aurora kinase A activity and the metabolic-epigenetic regulation underpinning trained immunity in innate immune cells. By demonstrating that inhibition of Aurora A disrupts β-glucan-induced trained immunity through modulation of S-adenosylmethionine (SAM) levels and histone methylation, the study provides a mechanistic bridge between cell cycle kinases and immune memory, with implications for both immunology and oncology.

• Partial BACE Inhibition Reduces Amyloid Beta Without Synapti

  2026-04-24

  Satir et al. (2020) demonstrate that moderate inhibition of BACE1—up to a 50% reduction in amyloid beta (Aβ) production—does not impair synaptic transmission in primary cortical neurons. These findings clarify dosing strategies for BACE inhibitors in Alzheimer’s disease research and highlight the safety window for modulating amyloid precursor protein processing.

• Prosapogenin A Triggers Pyroptosis in Anaplastic Thyroid Can

  2026-04-24

  This study demonstrates that Prosapogenin A induces GSDME-dependent pyroptosis in anaplastic thyroid cancer (ATC) cells by activating vacuolar ATPase and causing lysosomal over-acidification. The findings reveal a novel mechanism for ATC cell death and suggest new therapeutic strategies targeting lysosomal pathways.

• Baicalin Methyl Ester Restores LPS-Induced Intestinal Barrie

  2026-04-23

  This study demonstrates that baicalin methyl ester, an esterified derivative of baicalin, robustly protects against LPS-induced intestinal barrier damage in mice and MODE-K cells via modulation of the P65/TNF-α/MLCK/ZO-1 signaling pathway. The findings provide mechanistic insights and practical benchmarks for deploying BME as a targeted anti-inflammatory agent in preclinical intestinal inflammation models.

• Annexin V-APC/7-AAD Apoptosis Kit: Deep Assay Optimization I

  2026-04-23

  Explore advanced optimization and scientific context for the Annexin V-APC/7-AAD Apoptosis Kit. This cornerstone guide reveals mechanistic depth, protocol nuances, and translational insights for apoptosis detection kit users seeking robust, reproducible results.

• Entinostat (MS-275): Precision Epigenetic Modulation in Canc

  2026-04-22

  Explore how Entinostat (MS-275) harnesses selective HDAC inhibition to advance cancer cell proliferation research. This article uniquely synthesizes recent in vitro evaluation breakthroughs with practical assay optimization for oncology innovation.

• Shufeng Xingbi Therapy Modulates Th1/Th2 Balance and Gut Flo

  2026-04-22

  This study systematically evaluates Shufeng Xingbi Therapy's (SFXBT) effects on immune balance and intestinal microbiota in an ovalbumin-induced allergic rhinitis (AR) rat model. The findings highlight SFXBT's capacity to rebalance Th1/Th2 immunity, reduce allergic inflammation, and shift gut microbial composition—offering mechanistic insights for future research on immune-microbiota modulation strategies.

• Amplifying Translational Impact: Cy5 TSA Fluorescence in Dis

  2026-04-21

  Translational researchers face intensifying demands for sensitivity and spatial precision in interrogating molecular mechanisms underlying complex diseases such as atherosclerosis. This thought-leadership article synthesizes mechanistic insight from recent NLRP3 inflammasome studies with strategic guidance for deploying the Cy5 Tyramide Signal Amplification (TSA) Fluorescence System Kit, positioning APExBIO’s technology as a cornerstone for high-resolution, cost-effective detection of low-abundance targets. We critically evaluate competitive signal amplification platforms, anchor our recommendations in peer-reviewed findings, and chart a forward-looking perspective on the future of translational pathology.

• Imidazoline Antagonists Boost Insulin by Blocking β-Cell K+

  2026-04-21

  This study demonstrates that imidazoline antagonists of α2-adrenoceptors, such as phentolamine, increase insulin secretion in vitro by directly inhibiting ATP-sensitive potassium channels in pancreatic β-cells. The findings challenge the notion that their insulinotropic effect is solely due to adrenergic antagonism, highlighting a direct ion channel mechanism with implications for diabetes pharmacology.

• Gemcitabine: Precision Targeting of Tumor Metabolism & Immun

  2026-04-20

  Discover how Gemcitabine uniquely modulates tumor metabolism and immune escape in cancer research. This article delves into recent breakthroughs and practical assay strategies, providing new insights beyond standard apoptotic and DNA damage paradigms.

• Thiamet G: O-GlcNAcase Inhibitor Workflows for Disease Model

  2026-04-20

  Thiamet G empowers precision modulation of protein O-GlcNAcylation, facilitating breakthrough discoveries in neurodegeneration, leukemia, and bone biology. Its robust solubility, nanomolar potency, and proven in vivo brain penetration make it a gold-standard O-GlcNAcase inhibitor for experimental and translational research.

• Gamma-linolenic Acid (GLA): Immunomodulation Beyond Inflamma

  2026-04-19

  Explore how Gamma-linolenic acid (GLA) modulates inflammation and immune responses at a molecular level. This article offers advanced scientific insight and strategic assay guidance for researchers leveraging GLA in anti-inflammatory and immunology research.

• Safe DNA Gel Stain: Advancing DNA and RNA Gel Visualization

  2026-04-18

  Safe DNA Gel Stain from APExBIO transforms molecular biology workflows by providing high-sensitivity nucleic acid detection with dramatically reduced mutagenic risk. Its ability to enhance cloning efficiency and improve lab safety sets a new standard for DNA and RNA gel stain innovation.

• K+ Channel Blockade Alters Renal Blood Flow in Septic Rats

  2026-04-17

  This study investigates how blocking specific potassium channels affects renal blood flow responses to norepinephrine and phenylephrine in a rat sepsis model. The findings reveal that different K+ channel blockers can exacerbate reductions in renal perfusion when combined with vasoactive agents, highlighting nuanced channel roles in septic vascular dysfunction.

446 records 20/30 page Previous Next First page 上5页 1617181920 下5页 Last page